Elan posts ISEQ gains

Shares in Elan jumped almost 4% this morning after it said the latest trials of its multiple sclerosis drug Tysabri on people who have the disease showed significant positive effects on their quality of life.

Elan posts ISEQ gains

Shares in Elan jumped almost 4% this morning after it said the latest trials of its multiple sclerosis drug Tysabri on people who have the disease showed significant positive effects on their quality of life.

Elan were up 45c to €12.05.

You have reached your article limit. Already a subscriber? Sign in

Continue reading for €5

Unlock unlimited access and exclusive benefits

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited